Conference Report
Chitosan as a Nasal Delivery System: The Effect of Chitosan Solutions on in Vitro and in Vivo Mucociliary Transport Rates in Human Turbinates and Volunteers

https://doi.org/10.1021/js960182oGet rights and content

Abstract

In these studies, we examined the effect on mucociliary transport rates (MTR) of various 0.25% (w/v) chitosan solutions applied to human nasal tissue both ex vivo and in vivo. In the first study a range of chitosans with different molecular weights were applied to freshly amputated human nasal turbinates, and their effect on MTR was recorded. The transient inhibitory effect on turbinate MTR that was found for most of the chitosan preparations showed a marked dependence on the volume of chitosan solution applied and the molecular weight of the chitosan tested. The higher the molecular weight of the chitosan and the more chitosan applied, the longer the original MTR was depressed. A small scale human trial, investigating the effect of chitosan glutamate, on saccharin clearance times, was also undertaken. The study showed that a once daily application of a 0.25% solution of the chitosan for 7 days had no effect on either saccharin clearance times or nasal histology as examined by light microscopy.

References and Notes (31)

  • K. Nishimura et al.

    Vaccine

    (1985)
  • R. Muzzarelli et al.

    Biomaterials

    (1988)
  • T.J. Aspden et al.

    Eur. J. Pharm. Sci.

    (1996)
  • T.J. Aspden et al.

    Int. J. Pharm.

    (1995)
  • T. Sannan et al.

    Macromol. Chem.

    (1976)
  • M. Otterlei et al.

    Vaccine

    (1994)
  • K. Nishimura et al.

    Mol. Biother.

    (1990)
  • A.M. Papineau et al.

    Food Biotechnol.

    (1991)
  • L. Illum et al.

    Pharm. Res.

    (1994)
  • J.D.T. Mason et al.

    Clin. Otol.

    (1995)
  • I.B. Andersen et al.

    Am. Rev. Respir. Dis.

    (1974)
  • D. Passali et al.

    Acta. Otolaryngol. (Stockh).

    (1984)
  • H. Liote et al.

    Am. Rev. Respir. Dis.

    (1989)
  • H.J.M. Van der Donk et al.

    Int. J. Pharm.

    (1982)
  • K.J.A.O. Ingels et al.

    Arch. Otolaryn. Head Neck Surg.

    (1994)
  • Cited by (255)

    • Nanochitosan derived from marine annelids

      2023, Next Generation Nanochitosan: Applications in Animal Husbandry, Aquaculture and Food Conservation
    • Chitosan nanoparticles for intranasal delivery of olmesartan medoxomil: Pharmacokinetic and pharmacodynamic perspectives

      2022, International Journal of Pharmaceutics
      Citation Excerpt :

      Schipper et al. (1997) revealed in a similar investigation that CS attaches to Caco-2 cell monolayers via + charges and continues to have an impact after being withdrawn from the cell surfaces. The binding action may increase medicine retention at the application site, allowing for fewer applications and doses to be administered, and so enhancing patient tolerability (Schipper et al., 1997; Aspden et al., 1997). It was reported that both surface charges and PS improve the transmucosal permeation of NPs (Contri et al., 2016), which can be deduced from the small sizes and the high positively charges of the tested formulae.

    • Chitosan-based nanomaterials in drug delivery applications

      2021, Biopolymer-Based Nanomaterials in Drug Delivery and Biomedical Applications
    View all citing articles on Scopus
    View full text